Cargando…
Different mechanisms of two anti-anthrax protective antigen antibodies and function comparison between them
BACKGROUND: Bacillus anthracis causes a highly lethal infectious disease primarily due to toxin-mediated injury. Antibiotics are no longer effective to treat the accumulation of anthrax toxin, thereby new strategies of antibody treatment are essential. Two anti- anthrax protective antigen (PA) antib...
Autores principales: | Xiong, Siping, Zhou, Tingting, Zheng, Feng, Liang, Xudong, Cao, Yongping, Wang, Chunhui, Feng, Zhengqin, Tang, Qi, Zhu, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836657/ https://www.ncbi.nlm.nih.gov/pubmed/31699037 http://dx.doi.org/10.1186/s12879-019-4508-z |
Ejemplares similares
-
Human monoclonal anti-protective antigen antibody for the low-dose post-exposure prophylaxis and treatment of Anthrax
por: Tang, Qi, et al.
Publicado: (2018) -
A Novel Chimeric Anti-PA Neutralizing Antibody for Postexposure Prophylaxis and Treatment of Anthrax
por: Xiong, Siping, et al.
Publicado: (2015) -
Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed
por: Sawada-Hirai, Ritsuko, et al.
Publicado: (2004) -
Lethal Factor Toxemia and Anti-Protective Antigen Antibody Activity in Naturally Acquired Cutaneous Anthrax
por: Boyer, Anne E., et al.
Publicado: (2011) -
Preparation and Evaluation of Human-Murine Chimeric Antibody against Protective Antigen of Bacillus anthracis
por: Hao, Lina, et al.
Publicado: (2014)